Literature DB >> 6183443

Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.

E A Emini, B A Jameson, A J Lewis, G R Larsen, E Wimmer.   

Abstract

Two hybridomas (H3 and D3) secreting monoclonal neutralizing antibody to intact poliovirus type 1 (Mahoney strain) were established. Each antibody bound to a site qualitatively different from that to which the other antibody bound. The H3 site was located on intact virions and, to a lesser extent, on 80S naturally occurring empty capsids and 14S precursor subunits. The D3 site was found only on virions and empty capsids. Neither site was expressed on 80S heat-treated virions. The antibodies did not react with free denatured or undenatured viral structural proteins. Viral variants which were no longer capable of being neutralized by either one or the other antibody were obtained. Such variants arose during normal cell culture passage of wild-type virus and were present in the progeny viral population on the order of 10(-4) variant per wild-type virus PFU. Toluene-2,4-diisocyanate, a heterobifunctional covalent cross-linking reagent, was used to irreversibly bind the F(ab) fragments of the two antibodies to their respective binding sites. In this way, VP1 was identified as the structural protein containing both sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183443      PMCID: PMC256210     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity.

Authors:  K Lonberg-Holm; B E Butterworth
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

3.  [Neutralization of the infective power of the foot-and-mouth disease virus in cell culture by using serums from pigs immunized with a purified viral protein].

Authors:  J Laporte; J Grosclaude; J Wantyghem; S Bernard; P Rouzé
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1973-06-18

4.  On the structure of rhinovirus 1A.

Authors:  K C Medappa; C McLean; R R Rueckert
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

5.  The structure of heated poliovirus particles.

Authors:  M Breindl
Journal:  J Gen Virol       Date:  1971-06       Impact factor: 3.891

6.  In vitro assembly of poliovirus-related particles.

Authors:  B A Phillips; D F Summers; J V Maizel
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

7.  The coupling of chymotrypsinogen to bovine albumin.

Authors:  N D Boyd; M Ottosen
Journal:  Immunochemistry       Date:  1973-10

8.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

View more
  41 in total

1.  Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.

Authors:  Michael de Vrese; Peter Rautenberg; Christiane Laue; Marion Koopmans; Tineke Herremans; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2004-12-01       Impact factor: 5.614

2.  Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.

Authors:  Evaggelos Dedepsidis; Ioannis Karakasiliotis; Eleni Paximadi; Zaharoula Kyriakopoulou; Dimitrios Komiotis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

5.  Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.

Authors:  Zhaochun Chen; Elizabeth R Fischer; Diana Kouiavskaia; Bryan T Hansen; Steven J Ludtke; Bella Bidzhieva; Michelle Makiya; Liane Agulto; Robert H Purcell; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

6.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Functional analysis of the effect of monoclonal antibodies on monkey liver phenylalanine hydroxylase.

Authors:  I G Jennings; R G Russell; W L Armarego; R G Cotton
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

8.  Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.

Authors:  M M Herremans; J H Reimerink; A Ras; H G Van Der Avoort; T G Kimman; A M Van Loon; M A Conyn-Van Spaendonck; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

9.  Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.

Authors:  H Uhlig; F Haardt; R Dernick
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus.

Authors:  A M Nasser; T G Metcalf
Journal:  Appl Environ Microbiol       Date:  1987-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.